RU2259366C2 - Арипипразоловое лекарственное средство с низкой гигроскопичностью и способы его получения - Google Patents

Арипипразоловое лекарственное средство с низкой гигроскопичностью и способы его получения Download PDF

Info

Publication number: RU2259366C2
Authority: RU; Russia
Prior art keywords: crystals; aripiprazole; anhydrous; ppm; hydrate
Prior art date: 2001-09-25

Application number

RU2003101334/15A

Other languages

English (en)

Russian (ru)

Other versions

RU2003101334A (ru

Inventor

Такудзи БАНДО (JP)

Такудзи Бандо

Сатоси АОКИ (JP)

Сатоси АОКИ

Дзунити КАВАСАКИ (JP)

Дзунити Кавасаки

Макото ИСИГАМИ (JP)

Макото Исигами

Йоуити ТАНИГУТИ (JP)

Йоуити ТАНИГУТИ

Цуйоси ЯБУУТИ (JP)

Цуйоси ЯБУУТИ

Кийоси ФУДЗИМОТО (JP)

Кийоси Фудзимото

Йосихиро НИСИОКА (JP)

Йосихиро Нисиока

Нориюки КОБАЯСИ (JP)

Нориюки Кобаяси

Цутому ФУДЗИМУРА (JP)

Цутому Фудзимура

Масанори ТАКАХАСИ (JP)

Масанори Такахаси

Каору АБЕ (JP)

Каору АБЕ

Томонори НАКАГАВА (JP)

Томонори Накагава

Коити СИНХАМА (JP)

Коити Синхама

Наото УЦУМИ (JP)

Наото Уцуми

Митиаки ТОМИНАГА (JP)

Митиаки Томинага

Йосихиро ОИ (JP)

Йосихиро ОИ

Сохеи ЯМАДА (JP)

Сохеи Ямада

Кендзи ТОМИКАВА (JP)

Кендзи Томикава

Original Assignee

Оцука Фармасьютикал Ко., Лтд.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-25

Filing date

2002-09-25

Publication date

2005-08-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35846848&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2259366(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-03-27 Priority claimed from CA 2379005 external-priority patent/CA2379005A1/en

2002-09-25 Application filed by Оцука Фармасьютикал Ко., Лтд. filed Critical Оцука Фармасьютикал Ко., Лтд.

2004-05-10 Publication of RU2003101334A publication Critical patent/RU2003101334A/ru

2005-08-27 Application granted granted Critical

2005-08-27 Publication of RU2259366C2 publication Critical patent/RU2259366C2/ru

Links

238000000034 method Methods 0.000 title claims abstract description 174
239000013078 crystal Substances 0.000 claims abstract description 485
238000002329 infrared spectrum Methods 0.000 claims abstract description 47
239000003814 drug Substances 0.000 claims abstract description 44
238000010521 absorption reaction Methods 0.000 claims abstract description 22
239000008194 pharmaceutical composition Substances 0.000 claims abstract description 13
238000000113 differential scanning calorimetry Methods 0.000 claims abstract description 6
229960004372 aripiprazole Drugs 0.000 claims description 553
CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 claims description 375
-1 aripiprazole anhydride Chemical class 0.000 claims description 184
238000010438 heat treatment Methods 0.000 claims description 126
239000003826 tablet Substances 0.000 claims description 118
239000008187 granular material Substances 0.000 claims description 88
238000002360 preparation method Methods 0.000 claims description 85
238000001228 spectrum Methods 0.000 claims description 77
239000007787 solid Substances 0.000 claims description 76
239000000203 mixture Substances 0.000 claims description 71
238000000634 powder X-ray diffraction Methods 0.000 claims description 70
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 49
238000004090 dissolution Methods 0.000 claims description 43
229940079593 drug Drugs 0.000 claims description 42
238000004455 differential thermal analysis Methods 0.000 claims description 41
238000002411 thermogravimetry Methods 0.000 claims description 41
239000002245 particle Substances 0.000 claims description 36
238000001035 drying Methods 0.000 claims description 35
150000008064 anhydrides Chemical class 0.000 claims description 29
238000000227 grinding Methods 0.000 claims description 27
239000003937 drug carrier Substances 0.000 claims description 21
238000004519 manufacturing process Methods 0.000 claims description 21
238000002844 melting Methods 0.000 claims description 21
239000000843 powder Substances 0.000 claims description 21
201000000980 schizophrenia Diseases 0.000 claims description 16
239000000969 carrier Substances 0.000 claims description 13
238000005550 wet granulation Methods 0.000 claims description 11
238000003801 milling Methods 0.000 claims description 10
239000002994 raw material Substances 0.000 claims description 8
230000007423 decrease Effects 0.000 claims description 7
230000003340 mental effect Effects 0.000 claims description 6
206010026749 Mania Diseases 0.000 claims description 4
230000001684 chronic effect Effects 0.000 claims description 4
208000024827 Alzheimer disease Diseases 0.000 claims description 3
208000019901 Anxiety disease Diseases 0.000 claims description 3
208000020925 Bipolar disease Diseases 0.000 claims description 3
208000021384 Obsessive-Compulsive disease Diseases 0.000 claims description 3
230000036506 anxiety Effects 0.000 claims description 3
238000009434 installation Methods 0.000 claims description 3
208000007848 Alcoholism Diseases 0.000 claims description 2
208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims description 2
206010003805 Autism Diseases 0.000 claims description 2
208000020706 Autistic disease Diseases 0.000 claims description 2
201000010374 Down Syndrome Diseases 0.000 claims description 2
208000019695 Migraine disease Diseases 0.000 claims description 2
208000008589 Obesity Diseases 0.000 claims description 2
208000018737 Parkinson disease Diseases 0.000 claims description 2
201000001880 Sexual dysfunction Diseases 0.000 claims description 2
206010047700 Vomiting Diseases 0.000 claims description 2
201000007930 alcohol dependence Diseases 0.000 claims description 2
210000003169 central nervous system Anatomy 0.000 claims description 2
206010013663 drug dependence Diseases 0.000 claims description 2
206010027599 migraine Diseases 0.000 claims description 2
201000003152 motion sickness Diseases 0.000 claims description 2
230000004770 neurodegeneration Effects 0.000 claims description 2
208000015122 neurodegenerative disease Diseases 0.000 claims description 2
235000020824 obesity Nutrition 0.000 claims description 2
208000019906 panic disease Diseases 0.000 claims description 2
231100000872 sexual dysfunction Toxicity 0.000 claims description 2
208000019116 sleep disease Diseases 0.000 claims description 2
208000011117 substance-related disease Diseases 0.000 claims description 2
230000008673 vomiting Effects 0.000 claims description 2
208000024891 symptom Diseases 0.000 claims 4
239000007935 oral tablet Substances 0.000 claims 2
229940096978 oral tablet Drugs 0.000 claims 2
239000000126 substance Substances 0.000 abstract description 15
238000004458 analytical method Methods 0.000 abstract description 2
230000000694 effects Effects 0.000 abstract 1
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 66
238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 53
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 51
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 46
239000004615 ingredient Substances 0.000 description 43
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 42
239000000243 solution Substances 0.000 description 41
238000009472 formulation Methods 0.000 description 35
235000019359 magnesium stearate Nutrition 0.000 description 33
239000008186 active pharmaceutical agent Substances 0.000 description 30
229940088679 drug related substance Drugs 0.000 description 30
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 27
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 24
238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 17
238000005469 granulation Methods 0.000 description 17
230000003179 granulation Effects 0.000 description 16
239000000047 product Substances 0.000 description 16
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 15
239000008101 lactose Substances 0.000 description 15
230000008018 melting Effects 0.000 description 15
239000007858 starting material Substances 0.000 description 14
229920002472 Starch Polymers 0.000 description 13
239000008107 starch Substances 0.000 description 13
235000019698 starch Nutrition 0.000 description 13
238000012360 testing method Methods 0.000 description 13
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 12
229960000913 crospovidone Drugs 0.000 description 12
235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 12
229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 12
239000000725 suspension Substances 0.000 description 11
239000012085 test solution Substances 0.000 description 11
230000015572 biosynthetic process Effects 0.000 description 9
238000005243 fluidization Methods 0.000 description 9
238000005259 measurement Methods 0.000 description 9
HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 9
239000007788 liquid Substances 0.000 description 7
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
239000000378 calcium silicate Substances 0.000 description 6
229910052918 calcium silicate Inorganic materials 0.000 description 6
OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 6
229920002678 cellulose Polymers 0.000 description 6
239000001913 cellulose Substances 0.000 description 6
238000001816 cooling Methods 0.000 description 6
238000001914 filtration Methods 0.000 description 6
238000000926 separation method Methods 0.000 description 6
239000002904 solvent Substances 0.000 description 6
239000012086 standard solution Substances 0.000 description 6
229920002261 Corn starch Polymers 0.000 description 5
TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 5
238000002835 absorbance Methods 0.000 description 5
239000002775 capsule Substances 0.000 description 5
239000008120 corn starch Substances 0.000 description 5
230000018044 dehydration Effects 0.000 description 5
238000006297 dehydration reaction Methods 0.000 description 5
238000005516 engineering process Methods 0.000 description 5
HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 5
239000000546 pharmaceutical excipient Substances 0.000 description 5
239000012264 purified product Substances 0.000 description 5
238000001953 recrystallisation Methods 0.000 description 5
238000007873 sieving Methods 0.000 description 5
239000000811 xylitol Substances 0.000 description 5
235000010447 xylitol Nutrition 0.000 description 5
229960002675 xylitol Drugs 0.000 description 5
WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 4
101100135611 Arabidopsis thaliana PAP12 gene Proteins 0.000 description 4
108010011485 Aspartame Proteins 0.000 description 4
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
108010010803 Gelatin Proteins 0.000 description 4
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 4
239000000619 acesulfame-K Substances 0.000 description 4
239000002253 acid Substances 0.000 description 4
229910021486 amorphous silicon dioxide Inorganic materials 0.000 description 4
239000007864 aqueous solution Substances 0.000 description 4
239000003125 aqueous solvent Substances 0.000 description 4
239000000605 aspartame Substances 0.000 description 4
235000010357 aspartame Nutrition 0.000 description 4
IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 4
229960003438 aspartame Drugs 0.000 description 4
239000011230 binding agent Substances 0.000 description 4
238000007906 compression Methods 0.000 description 4
230000006835 compression Effects 0.000 description 4
235000009508 confectionery Nutrition 0.000 description 4
HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 4
239000007884 disintegrant Substances 0.000 description 4
239000003205 fragrance Substances 0.000 description 4
239000008273 gelatin Substances 0.000 description 4
229920000159 gelatin Polymers 0.000 description 4
235000019322 gelatine Nutrition 0.000 description 4
235000011852 gelatine desserts Nutrition 0.000 description 4
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 4
239000001863 hydroxypropyl cellulose Substances 0.000 description 4
238000003756 stirring Methods 0.000 description 4
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
239000005995 Aluminium silicate Substances 0.000 description 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
235000010724 Wisteria floribunda Nutrition 0.000 description 3
235000012211 aluminium silicate Nutrition 0.000 description 3
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
239000007853 buffer solution Substances 0.000 description 3
229910052799 carbon Inorganic materials 0.000 description 3
229940110456 cocoa butter Drugs 0.000 description 3
235000019868 cocoa butter Nutrition 0.000 description 3
238000010586 diagram Methods 0.000 description 3
238000001704 evaporation Methods 0.000 description 3
230000008020 evaporation Effects 0.000 description 3
239000008103 glucose Substances 0.000 description 3
150000004677 hydrates Chemical class 0.000 description 3
NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 3
239000000314 lubricant Substances 0.000 description 3
238000002156 mixing Methods 0.000 description 3
239000000825 pharmaceutical preparation Substances 0.000 description 3
239000006187 pill Substances 0.000 description 3
238000012545 processing Methods 0.000 description 3
FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
239000000829 suppository Substances 0.000 description 3
238000010998 test method Methods 0.000 description 3
238000005303 weighing Methods 0.000 description 3
UDQMXYJSNNCRAS-UHFFFAOYSA-N 2,3-dichlorophenylpiperazine Chemical compound ClC1=CC=CC(N2CCNCC2)=C1Cl UDQMXYJSNNCRAS-UHFFFAOYSA-N 0.000 description 2
BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 2
URHLNHVYMNBPEO-UHFFFAOYSA-N 7-(4-bromobutoxy)-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(=O)NC2=CC(OCCCCBr)=CC=C21 URHLNHVYMNBPEO-UHFFFAOYSA-N 0.000 description 2
229920001817 Agar Polymers 0.000 description 2
PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
239000003463 adsorbent Substances 0.000 description 2
239000008272 agar Substances 0.000 description 2
235000010419 agar Nutrition 0.000 description 2
230000002776 aggregation Effects 0.000 description 2
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
229910052782 aluminium Inorganic materials 0.000 description 2
238000009835 boiling Methods 0.000 description 2
229910000019 calcium carbonate Inorganic materials 0.000 description 2
235000010216 calcium carbonate Nutrition 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
208000035475 disorder Diseases 0.000 description 2
229940126534 drug product Drugs 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
239000000463 material Substances 0.000 description 2
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
239000003960 organic solvent Substances 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
238000010992 reflux Methods 0.000 description 2
RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
235000012239 silicon dioxide Nutrition 0.000 description 2
235000017281 sodium acetate Nutrition 0.000 description 2
229940087562 sodium acetate trihydrate Drugs 0.000 description 2
235000019333 sodium laurylsulphate Nutrition 0.000 description 2
229910001220 stainless steel Inorganic materials 0.000 description 2
239000010935 stainless steel Substances 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
238000001757 thermogravimetry curve Methods 0.000 description 2
238000004448 titration Methods 0.000 description 2
238000004481 total suppression of sideband Methods 0.000 description 2
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
238000003221 volumetric titration Methods 0.000 description 2
LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
238000004922 13C solid-state nuclear magnetic resonance spectroscopy Methods 0.000 description 1
SRMLSNBGMDJSJH-UHFFFAOYSA-N 7-(4-chlorobutoxy)-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(=O)NC2=CC(OCCCCCl)=CC=C21 SRMLSNBGMDJSJH-UHFFFAOYSA-N 0.000 description 1
244000215068 Acacia senegal Species 0.000 description 1
241000416162 Astragalus gummifer Species 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
AQVPWNRHUPHDPD-UHFFFAOYSA-N Cl.ClC1=C(C=CC=C1Cl)N1CCCCC1 Chemical compound Cl.ClC1=C(C=CC=C1Cl)N1CCCCC1 AQVPWNRHUPHDPD-UHFFFAOYSA-N 0.000 description 1
229910002483 Cu Ka Inorganic materials 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
206010012218 Delirium Diseases 0.000 description 1
239000004386 Erythritol Substances 0.000 description 1
UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
229920000084 Gum arabic Polymers 0.000 description 1
208000004547 Hallucinations Diseases 0.000 description 1
229920001543 Laminarin Polymers 0.000 description 1
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
239000004909 Moisturizer Substances 0.000 description 1
208000002193 Pain Diseases 0.000 description 1
229920001214 Polysorbate 60 Polymers 0.000 description 1
208000028017 Psychotic disease Diseases 0.000 description 1
229920001800 Shellac Polymers 0.000 description 1
UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
238000002083 X-ray spectrum Methods 0.000 description 1
239000003655 absorption accelerator Substances 0.000 description 1
229940124532 absorption promoter Drugs 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
239000000205 acacia gum Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
238000005054 agglomeration Methods 0.000 description 1
238000004220 aggregation Methods 0.000 description 1
230000032683 aging Effects 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
230000002932 anti-schizophrenic effect Effects 0.000 description 1
229940112350 aripiprazole 5 mg Drugs 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
239000003693 atypical antipsychotic agent Substances 0.000 description 1
238000010533 azeotropic distillation Methods 0.000 description 1
239000000440 bentonite Substances 0.000 description 1
229910000278 bentonite Inorganic materials 0.000 description 1
SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
230000037396 body weight Effects 0.000 description 1
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
239000004327 boric acid Substances 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
235000013877 carbamide Nutrition 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
238000000576 coating method Methods 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000004891 communication Methods 0.000 description 1
238000005384 cross polarization magic-angle spinning Methods 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
229910001873 dinitrogen Inorganic materials 0.000 description 1
FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
238000007922 dissolution test Methods 0.000 description 1
238000009826 distribution Methods 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
239000008298 dragée Substances 0.000 description 1
239000000975 dye Substances 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
238000013399 early diagnosis Methods 0.000 description 1
239000002662 enteric coated tablet Substances 0.000 description 1
UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
235000019414 erythritol Nutrition 0.000 description 1
229940009714 erythritol Drugs 0.000 description 1
238000001125 extrusion Methods 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000945 filler Substances 0.000 description 1
238000011049 filling Methods 0.000 description 1
239000007941 film coated tablet Substances 0.000 description 1
229940047127 fiore Drugs 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
238000009477 fluid bed granulation Methods 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
235000001727 glucose Nutrition 0.000 description 1
125000005456 glyceride group Chemical group 0.000 description 1
235000011187 glycerol Nutrition 0.000 description 1
239000010439 graphite Substances 0.000 description 1
229910002804 graphite Inorganic materials 0.000 description 1
YUWFEBAXEOLKSG-UHFFFAOYSA-N hexamethylbenzene Chemical compound CC1=C(C)C(C)=C(C)C(C)=C1C YUWFEBAXEOLKSG-UHFFFAOYSA-N 0.000 description 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
238000004898 kneading Methods 0.000 description 1
DBTMGCOVALSLOR-VPNXCSTESA-N laminarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](O)C(O[C@H]2[C@@H]([C@@H](CO)OC(O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-VPNXCSTESA-N 0.000 description 1
229940050906 magnesium chloride hexahydrate Drugs 0.000 description 1
DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
239000011812 mixed powder Substances 0.000 description 1
230000001333 moisturizer Effects 0.000 description 1
239000012768 molten material Substances 0.000 description 1
201000006417 multiple sclerosis Diseases 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
239000012299 nitrogen atmosphere Substances 0.000 description 1
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
239000002304 perfume Substances 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
229910000027 potassium carbonate Inorganic materials 0.000 description 1
229910000160 potassium phosphate Inorganic materials 0.000 description 1
235000011009 potassium phosphates Nutrition 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002265 prevention Effects 0.000 description 1
238000010298 pulverizing process Methods 0.000 description 1
150000003242 quaternary ammonium salts Chemical class 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
238000005464 sample preparation method Methods 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
239000000565 sealant Substances 0.000 description 1
ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
239000004208 shellac Substances 0.000 description 1
235000013874 shellac Nutrition 0.000 description 1
229940113147 shellac Drugs 0.000 description 1
235000010413 sodium alginate Nutrition 0.000 description 1
239000000661 sodium alginate Substances 0.000 description 1
229940005550 sodium alginate Drugs 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
235000002639 sodium chloride Nutrition 0.000 description 1
235000009518 sodium iodide Nutrition 0.000 description 1
239000007901 soft capsule Substances 0.000 description 1
238000000371 solid-state nuclear magnetic resonance spectroscopy Methods 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
235000010356 sorbitol Nutrition 0.000 description 1
239000008347 soybean phospholipid Substances 0.000 description 1
238000004611 spectroscopical analysis Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000007940 sugar coated tablet Substances 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000007916 tablet composition Substances 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
235000012222 talc Nutrition 0.000 description 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
235000010487 tragacanth Nutrition 0.000 description 1
239000000196 tragacanth Substances 0.000 description 1
229940116362 tragacanth Drugs 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
230000004580 weight loss Effects 0.000 description 1

Images

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

RU2003101334/15A 2001-09-25 2002-09-25 Арипипразоловое лекарственное средство с низкой гигроскопичностью и способы его получения RU2259366C2 (ru)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
JP2001-290645		2001-09-25
JP2001290645		2001-09-25
JP2001-348276		2001-11-14
CA 2379005 CA2379005A1 (en)	2001-09-25	2002-03-27	Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
CA2379005		2002-03-27

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
RU2004126636/04A Division RU2279429C2 (ru)	2001-09-25	2002-09-25	Арипипразоловое лекарственное средство с низкой гигроскопичностью и способы его получения

Publications (2)

Publication Number	Publication Date
RU2003101334A RU2003101334A (ru)	2004-05-10
RU2259366C2 true RU2259366C2 (ru)	2005-08-27

Family

ID=35846848

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
RU2003101334/15A RU2259366C2 (ru)	2001-09-25	2002-09-25	Арипипразоловое лекарственное средство с низкой гигроскопичностью и способы его получения

Country Status (2)

Country	Link
RU (1)	RU2259366C2 (xx)
UA (1)	UA80802C2 (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2555760C2 (ru) *	2009-09-11	2015-07-10	Оцука Фармасьютикал Ко., Лтд.	Терапевтический агент против хронической боли

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUP0500683A3 (en) *	2005-07-14	2009-03-30	Egis Gyogyszergyar Nyilvanosan	New arylpiprazole salts for producing pharmaceutical composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4803203A (en) *	1986-11-05	1989-02-07	Warner-Lambert Company	Phenyl and heterocyclic piperazinyl alkoxy-benzheterocyclic compounds as antipsychotic agents
US4828840A (en) *	1986-07-17	1989-05-09	Shionogi & Co., Ltd.	Sustained-release formulation and production thereof
US5006528A (en) *	1988-10-31	1991-04-09	Otsuka Pharmaceutical Co., Ltd.	Carbostyril derivatives

2002
- 2002-09-25 UA UA2003010503A patent/UA80802C2/xx unknown
- 2002-09-25 RU RU2003101334/15A patent/RU2259366C2/ru active

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4828840A (en) *	1986-07-17	1989-05-09	Shionogi & Co., Ltd.	Sustained-release formulation and production thereof
US4803203A (en) *	1986-11-05	1989-02-07	Warner-Lambert Company	Phenyl and heterocyclic piperazinyl alkoxy-benzheterocyclic compounds as antipsychotic agents
US5006528A (en) *	1988-10-31	1991-04-09	Otsuka Pharmaceutical Co., Ltd.	Carbostyril derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2555760C2 (ru) *	2009-09-11	2015-07-10	Оцука Фармасьютикал Ко., Лтд.	Терапевтический агент против хронической боли

Also Published As

Publication number	Publication date
UA80802C2 (en)	2007-11-12

Publication	Publication Date	Title
US20210395204A1 (en)	2021-12-23	Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
AU2002334413A1 (en)	2003-06-26	Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
RU2279429C2 (ru)	2006-07-10	Арипипразоловое лекарственное средство с низкой гигроскопичностью и способы его получения
RU2259366C2 (ru)	2005-08-27	Арипипразоловое лекарственное средство с низкой гигроскопичностью и способы его получения
US8703772B2 (en)	2014-04-22	Low hygroscopic aripiprazole drug substance and processes for the preparation thereof

RU2259366C2 - Арипипразоловое лекарственное средство с низкой гигроскопичностью и способы его получения - Google Patents

Info

Links

Images

Landscapes

Applications Claiming Priority (5)

Related Child Applications (1)

Publications (2)

Family

ID=35846848

Family Applications (1)

Country Status (2)

Cited By (1)

Families Citing this family (1)

Citations (3)

Patent Citations (3)

Cited By (1)

Also Published As

Similar Documents